CFTR and cystic fibrosis: In clinical trials, however, VX-809 treatment was able to improve functional expression of ΔF508-CFTR in the sweat gland but failed to show robust improvement in lung function of patients with CF who were homozygous for the F508del-CFTR mutation [15].